Can beetroot consumption increase bleeding risk in patients on anticoagulant or antiplatelet therapy or with bleeding disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Beetroot Does Not Cause Bleeding

Beetroot consumption does not increase bleeding risk in patients on anticoagulant or antiplatelet therapy, nor in those with bleeding disorders. There is no evidence in medical literature linking beetroot to increased bleeding complications.

Why This Question Arises

The confusion likely stems from beetroot's red pigmentation (betacyanin), which can cause red discoloration of urine and stool—a benign condition called beeturia that affects 10-14% of the population. This harmless pigment excretion is sometimes mistaken for hematuria or gastrointestinal bleeding, but it represents no actual blood loss.

What the Evidence Shows About Actual Bleeding Risks

The provided guidelines extensively address bleeding risks associated with antiplatelet and anticoagulant medications 1, but none mention dietary factors like beetroot as bleeding risk factors. The established risk factors for bleeding in anticoagulated patients include:

  • Prior history of GI bleeding (strongest predictor) 1
  • Advanced age 1
  • Concurrent medications: NSAIDs, corticosteroids, anticoagulants, SSRIs 1, 2
  • H. pylori infection 1
  • Underlying GI pathology: peptic ulcers, malignancy, diverticulosis, angiodysplasia 2
  • Dual antiplatelet therapy (increases GI bleeding 2-3 fold vs aspirin alone) 1

Beetroot's Actual Cardiovascular Effects

Recent research shows beetroot juice may actually benefit patients with peripheral artery disease through its nitrate content, which converts to nitric oxide—improving blood flow, lowering blood pressure, and enhancing endothelial function 3. These are vasodilatory effects, not anticoagulant or antiplatelet effects.

Clinical Pitfall to Avoid

Do not confuse beeturia (red urine/stool from beetroot pigment) with actual hematuria or GI bleeding. If a patient on anticoagulation reports red urine after eating beetroot:

  • Ask specifically about beetroot consumption in the preceding 24-48 hours
  • Perform urinalysis to distinguish pigment from blood (beeturia will not show RBCs or hemoglobin on dipstick)
  • For suspected GI bleeding, perform fecal occult blood testing rather than relying on visual inspection alone

Bottom Line

Continue anticoagulant and antiplatelet therapy as indicated without concern for beetroot consumption. Focus bleeding risk assessment on the evidence-based factors listed above 1, 2. There is no need to counsel patients to avoid beetroot while on antithrombotic therapy.

Related Questions

In a patient with a gastrointestinal bleed who is anticoagulated (e.g., on warfarin or a direct oral anticoagulant), how should intraoperative clot removal be performed?
In a 44-year-old woman (height 146 cm, weight 43 kg, BMI 20.2) with normal vital signs, normal renal and hepatic function, and no history of thromboembolic disease, malignancy, thrombophilia, or anticoagulant therapy, what is the risk of thromboembolic complications and surgical bleeding during a planned rectal polyp and hemorrhoidal nodule excision, and is pharmacologic thromboprophylaxis required?
How should a nursing home patient with a Foley catheter who develops gross hematuria with clots, but no shortness of breath, be managed?
Does aspirin cause hematuria and what is the appropriate management?
How should acute anemia be managed in a patient taking apixaban (Eliquis) and aspirin?
In a patient with rhabdomyolysis, how frequently should laboratory studies (creatine kinase, electrolytes, renal function) be obtained during hospitalization and after discharge, and when should outpatient follow‑up be scheduled?
I am currently on 16 units of basal insulin daily and my fasting glucose this morning was 300 mg/dL; how should I adjust my insulin regimen?
In a patient with significant tongue movements and lip‑smacking (orofacial dyskinesia), is Austedo (dextromethorphan/quinidine) appropriate?
Is it safe to use alprazolam together with hydroxyzine or diphenhydramine?
Does zeaxanthin increase the risk of bleeding?
What hematology clearance is needed for a patient on rivaroxaban undergoing multiple dental extractions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.